Jamaican doctor appointed head of UCLA Department of Medicine jamaicaobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamaicaobserver.com Daily Mail and Mail on Sunday newspapers.
Print
Gerald Levey, the administrator who oversaw the construction of Ronald Reagan UCLA Medical Center after the Northridge earthquake damaged the university’s hospital building, has died at his home in Los Angeles.
Levey, who died June 25, had Parkinson’s disease. He was 84.
During his tenure as vice chancellor of medical sciences and dean of the David Geffen School of Medicine at UCLA from 1994 to 2010, Levey also played a pivotal role in reshaping the medical school’s curriculum and led the building of five research buildings as well as the UCLA medical center in Santa Monica, according to the university.
UCLA Health
Dr. Gerald Levey at the entrance to Ronald Reagan UCLA Medical Center, in front of a wall honoring his service as vice chancellor of health sciences and dean of the David Geffen School of Medicine at UCLA. Elaine Schmidt |
June 29, 2021
Dr. Gerald Levey, who led the transformation of UCLA’s hospitals and medical school into a world-class academic health system, died at home of Parkinson’s disease on June 25. He was 84.
Levey served the campus as vice chancellor of medical sciences and dean of the David Geffen School of Medicine at UCLA from 1994 to 2010. During his tenure, Levey amassed an extraordinarily long list of achievements, crowned by the construction of the Ronald Reagan UCLA Medical Center and the sealing of a $200 million gift to the UCLA School of Medicine by entertainment executive David Geffen.
LOS ANGELES (CNS) UCLA has received a $29 million gift to establish a center where scientists and physicians will work side by side to examine the role of genetics in disease, and develop therapies that improve patients lives, it was announced Thursday.
The gift creates the Dr. Allen and Charlotte Ginsburg Center for Precision Genomic Medicine. The new center will build on UCLA s efforts in precision health to leverage large data sets and innovative genomic technologies such as CRISPR engineering to improve diagnosis and treatment of a wide variety of genetic disorders including both rare diseases and more common illnesses such as cardiovascular disease, cancer and immune disorders, diseases of the eye and brain disorders such as autism, Parkinson s and Alzheimer s.